Search research articles

Search research articles

Related Experiment Videos

Selection bias in clinical trials.

K D Miller¹, Z U Rahman, G W Sledge

¹Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA. kathmill@iupui.edu

|February 3, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genomic landscape, immune microenvironment and survival in male versus female breast cancer.

ESMO open·2026

Same author

Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancer.

ESMO open·2025

Same author

Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors.

Scientific reports·2025

Same author

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Same author

Correction to: Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research.

Breast cancer research and treatment·2022

Same author

Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research.

Breast cancer research and treatment·2022

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Selection bias systematically distorts clinical trial results. This review details common sources of selection bias and offers strategies to avoid these pitfalls in clinical research.

Area of Science:

Clinical research methodology
Biostatistics
Medical research integrity

Background:

Research findings can be systematically distorted by various biases.
Over 50 types of analytical research bias have been identified.
Selection bias presents a unique challenge in clinical trials.

Purpose of the Study:

To focus on the specific problem of selection bias in clinical trials.
To demonstrate the systematic nature of selection bias in clinical research.
To provide practical strategies for avoiding selection bias.

Main Methods:

Review of identified sources of bias in analytical research.
Focus on selection bias within the context of clinical trials.
Illustrative example using high-dose chemotherapy for breast cancer.

Related Experiment Videos

Main Results:

Common sources of selection bias in clinical trials include inappropriate use of historical controls, stage migration, restrictive inclusion/exclusion criteria, multiple subset analyses, and investigator bias.
Selection bias is a systematic issue that can significantly distort clinical research outcomes.
High-dose chemotherapy for breast cancer serves as a case study for understanding these biases.

Conclusions:

Awareness of common selection bias sources is crucial for researchers.
Implementing strategies to mitigate selection bias is essential for maintaining research integrity.
Avoiding selection bias traps enhances the reliability and validity of clinical trial results.